These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16567609)

  • 1. Type 2 diabetes mellitus in midlife estimated from the Cambridge Risk Score and body mass index.
    Thomas C; Hyppönen E; Power C
    Arch Intern Med; 2006 Mar; 166(6):682-8. PubMed ID: 16567609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of glycated hemoglobin in screening and diagnosing type 2 diabetes mellitus in Chinese subjects.
    Yu Y; Ouyang XJ; Lou QL; Gu LB; Mo YZ; Ko GT; Chow CC; So WY; Ma R; Kong A; Brown N; Nan J; Chan J; Bian RW
    Korean J Intern Med; 2012 Mar; 27(1):41-6. PubMed ID: 22403498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening.
    Schöttker B; Raum E; Rothenbacher D; Müller H; Brenner H
    Eur J Epidemiol; 2011 Oct; 26(10):779-87. PubMed ID: 21947790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a new scoring system for predicting the 5 year incidence of type 2 diabetes in Japan: the Toranomon Hospital Health Management Center Study 6 (TOPICS 6).
    Heianza Y; Arase Y; Hsieh SD; Saito K; Tsuji H; Kodama S; Tanaka S; Ohashi Y; Shimano H; Yamada N; Hara S; Sone H
    Diabetologia; 2012 Dec; 55(12):3213-23. PubMed ID: 22955996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidity and glycemic control in patients with type 2 diabetes.
    El-Kebbi IM; Ziemer DC; Cook CB; Miller CD; Gallina DL; Phillips LS
    Arch Intern Med; 2001 May; 161(10):1295-300. PubMed ID: 11371257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hba(1c) as a tool for the diagnosis of type 2 diabetes: comparison with fasting glucose.
    Tatsch E; Bochi GV; Piva SJ; Pereira RS; Kober H; De Carvalho JA; Sangoi MB; Duarte MM; Moresco RN
    Clin Lab; 2012; 58(3-4):347-50. PubMed ID: 22582512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in BMI, duration of overweight and obesity, and glucose metabolism: 45 years of follow-up of a birth cohort.
    Power C; Thomas C
    Diabetes Care; 2011 Sep; 34(9):1986-91. PubMed ID: 21775760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort: does adding glycated hemoglobin improve the prediction of coronary heart disease events?
    Simmons RK; Sharp S; Boekholdt SM; Sargeant LA; Khaw KT; Wareham NJ; Griffin SJ
    Arch Intern Med; 2008 Jun; 168(11):1209-16. PubMed ID: 18541829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the potential population impact of stepwise screening strategies for identifying and treating individuals at high risk of Type 2 diabetes: a modelling study.
    Chamnan P; Simmons RK; Khaw KT; Wareham NJ; Griffin SJ
    Diabet Med; 2012 Jul; 29(7):893-904. PubMed ID: 22340130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes risk in British adults in mid life: a national prevalence study of glycated haemoglobin.
    Thomas C; Hyppönen E; Power C
    Diabet Med; 2007 Mar; 24(3):317-21. PubMed ID: 17305791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HbA1c 5·7-6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study.
    Heianza Y; Hara S; Arase Y; Saito K; Fujiwara K; Tsuji H; Kodama S; Hsieh SD; Mori Y; Shimano H; Yamada N; Kosaka K; Sone H
    Lancet; 2011 Jul; 378(9786):147-55. PubMed ID: 21705064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HbA(1c) in the prediction of type 2 diabetes compared with fasting and 2-h post-challenge plasma glucose: The Asturias study (1998-2005).
    Valdés S; Botas P; Delgado E; Alvarez F; Díaz-Cadórniga F
    Diabetes Metab; 2011 Feb; 37(1):27-32. PubMed ID: 20934897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential impact of using glycated haemoglobin as the preferred diagnostic tool for detecting Type 2 diabetes mellitus.
    Mostafa SA; Davies MJ; Webb D; Gray LJ; Srinivasan BT; Jarvis J; Khunti K
    Diabet Med; 2010 Jul; 27(7):762-9. PubMed ID: 20636956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemoglobin A1c cut-off point to identify a high risk group of future diabetes: results from the Omiya MA Cohort Study.
    Kato M; Noda M; Suga H; Nakamura T; Matsumoto M; Kanazawa Y;
    Diabet Med; 2012 Jul; 29(7):905-10. PubMed ID: 22248349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in weight and diabetes compensation (HbA(1c)) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic - BIBY-I study (observations lasting 3 to 12 months)].
    Perusicová J; Haladová I; Pit'hová P; Acsová D; Belobrádková J; Belzová A; Berková K; Dolezalová B; Dvoráková H; Hejnicová K; Hudcová M; Kallmünzerová D; Krejsová Z; Markofová G; Müllerová H; Owen K; Pelikánová M; Raclavská L; Racická E; Skarpová O; Váchová A; Veselá A; Vyoralos J; Broz J; Edelsberger T; Honka M; Hrdina T; Chmura P; Tosovský J
    Vnitr Lek; 2013 Mar; 59(3):165-71. PubMed ID: 23713182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of glycemic variability and glycated hemoglobin as risk factors of coronary artery disease in patients with undiagnosed diabetes.
    Mi SH; Su G; Li Z; Yang HX; Zheng H; Tao H; Zhou Y; Tian L
    Chin Med J (Engl); 2012 Jan; 125(1):38-43. PubMed ID: 22340463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of obesity with hyperglycemia is a risk factor for the presence of vertebral fractures in type 2 diabetic men.
    Kanazawa I; Yamaguchi T; Yamamoto M; Yamauchi M; Yano S; Sugimoto T
    Calcif Tissue Int; 2008 Nov; 83(5):324-31. PubMed ID: 18946627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review.
    Bennett CM; Guo M; Dharmage SC
    Diabet Med; 2007 Apr; 24(4):333-43. PubMed ID: 17367307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of type 2 diabetes by HbA1c and OGTT: the Isfahan Diabetes Prevention Study.
    Janghorbani M; Amini M
    Acta Diabetol; 2012 Dec; 49 Suppl 1():S73-9. PubMed ID: 21340503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using HbA(1c) to improve efficacy of the american diabetes association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians: the strong heart study.
    Wang W; Lee ET; Fabsitz R; Welty TK; Howard BV
    Diabetes Care; 2002 Aug; 25(8):1365-70. PubMed ID: 12145236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.